Sufficient conditions for the existence of an isolated solution to a nonlocal boundary value problem for a nonlinear third-order pseudoparabolic equation
Filomat · 2025 · 39 (33) · 11811-11824
DOI: 10.2298/fil2533811o ↗Kurz gefasst
Fachartikel in der Zeitschrift Filomat, 2025. Verfasst von Nurgul Orumbayeva und 2 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0).
Abstract (Originalsprache)
In this paper, a third-order nonlinear pseudo-parabolic equation with nonlocal boundary con-ditions is studied. The original boundary value problem is reduced to a multicharacteristic nonlinear boundary value problem with functional parameters. Subsequently, the resulting problem is transformed into a system of integro-differential equations, which enables the proposal of an iterative algorithm for finding the solution. Sufficient conditions for the existence, uniqueness, and convergence of the solution are established. It is proved that the sequence of approximations generated by this algorithm converges to an isolated solution of the problem.
Zitieren
APA
Orumbayeva, N., Manat, A., & Tokmagambetova, T. (2025). Sufficient conditions for the existence of an isolated solution to a nonlocal boundary value problem for a nonlinear third-order pseudoparabolic equation. Filomat, 39(33), 11811-11824. https://doi.org/10.2298/fil2533811o
Vancouver
Orumbayeva N, Manat A, Tokmagambetova T. Sufficient conditions for the existence of an isolated solution to a nonlocal boundary value problem for a nonlinear third-order pseudoparabolic equation. Filomat. 2025;39(33):11811-11824. doi:10.2298/fil2533811o
BibTeX
@article{Orumbayeva2025,
author = {Orumbayeva, Nurgul and Manat, Alua and Tokmagambetova, Tenggesh},
title = {Sufficient conditions for the existence of an isolated solution to a nonlocal boundary value problem for a nonlinear third-order pseudoparabolic equation},
journal = {Filomat},
year = {2025},
volume = {39},
number = {33},
pages = {11811--11824},
doi = {10.2298/fil2533811o}
}
EUVIMED